shutterstock_1696929460_m_foto

M-Foto / Shutterstock.com

12 August 2021AmericasAlex Baldwin

Brazil passes compulsory licence bill for COVID-19 vaccines

The Brazilian Senate Plenary has approved a bill that will allow President Bolsonaro to waive patent protections for COVID-19 vaccines.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Brazil Supreme Court suspends drug patent extensions

8 April 2021 Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19.

Australia backs COVID-19 vaccine waiver

9 September 2021 Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

More on this story

Australia backs COVID-19 vaccine waiver

9 September 2021 Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

Brazil Supreme Court suspends drug patent extensions

8 April 2021 Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19.

More on this story

Australia backs COVID-19 vaccine waiver

9 September 2021 Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

Brazil Supreme Court suspends drug patent extensions

8 April 2021 Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent